Brief: Virpax Reports Pricing of $40 Mln Public Offering of Common Stock
14/09/2021 14:07
Sept 14 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX® PHARMACEUTICALS ANNOUNCES PRICING OF $40 MILLION
PUBLIC
OFFERING OF COMMON STOCK
* VIRPAX PHARMACEUTICALS INC - PRICING OF UNDERWRITTEN
PUBLIC
OFFERING OF 6.7 MILLION SHARES OF ITS COMMON STOCK AT $6.00 PER
SHARE
Source text for Eikon: ID:nBwbmcCkda
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study